Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 3 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
JAMA Oncol. 2022 Apr 1;8(4):587-596. doi: 10.1001/jamaoncol.2021.6204.
JAMA Oncol. 2022.
PMID: 35175286
Free PMC article.
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S, Geuzinge HA, Rutgers EJT, Mann RM, de Roy van Zuidewijn DBW, Zonderland HM, Tollenaar RAEM, Lobbes MBI, Ausems MGEM, van 't Riet M, Hooning MJ, Mares-Engelberts I, Luiten EJT, Heijnsdijk EAM, Verhoef C, Karssemeijer N, Oosterwijk JC, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MMA; FaMRIsc study group.
Saadatmand S, et al. Among authors: geuzinge ha.
Lancet Oncol. 2019 Aug;20(8):1136-1147. doi: 10.1016/S1470-2045(19)30275-X. Epub 2019 Jun 17.
Lancet Oncol. 2019.
PMID: 31221620
Clinical Trial.
Item in Clipboard
Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue.
Geuzinge HA, Bakker MF, Heijnsdijk EAM, van Ravesteyn NT, Veldhuis WB, Pijnappel RM, de Lange SV, Emaus MJ, Mann RM, Monninkhof EM, de Koekkoek-Doll PK, van Gils CH, de Koning HJ; DENSE trial study group.
Geuzinge HA, et al.
J Natl Cancer Inst. 2021 Nov 2;113(11):1476-1483. doi: 10.1093/jnci/djab119.
J Natl Cancer Inst. 2021.
PMID: 34585249
Free PMC article.
Item in Clipboard
Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios.
Zielonke N, Geuzinge A, Heijnsdijk EAM, Heinävaara S, Senore C, Jarm K, de Koning HJ, van Ravesteyn NT, On Behalf Of The Eu-Topia Consortium.
Zielonke N, et al. Among authors: geuzinge a.
Cancers (Basel). 2021 Jul 4;13(13):3360. doi: 10.3390/cancers13133360.
Cancers (Basel). 2021.
PMID: 34283068
Free PMC article.
Item in Clipboard
Effects of a leaflet on breast cancer screening knowledge, explicit attitudes, and implicit associations.
Kregting LM, van Ravesteyn NT, Spijker W, Dierks T, Aitken CA, Geuzinge HA, Korfage IJ.
Kregting LM, et al. Among authors: geuzinge ha.
Patient Educ Couns. 2020 Jul 2:S0738-3991(20)30350-5. doi: 10.1016/j.pec.2020.06.032. Online ahead of print.
Patient Educ Couns. 2020.
PMID: 32732022
Free article.
Item in Clipboard
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge HA, Obdeijn IM, Rutgers EJT, Saadatmand S, Mann RM, Oosterwijk JC, Tollenaar RAEM, de Roy van Zuidewijn DBW, Lobbes MBI, van 't Riet M, Hooning MJ, Ausems MGEM, Loo CE, Wesseling J, Luiten EJT, Zonderland HM, Verhoef C, Heijnsdijk EAM, Tilanus-Linthorst MMA, de Koning HJ; Familial MRI Screening (FaMRIsc) Study group.
Geuzinge HA, et al.
JAMA Oncol. 2020 Sep 1;6(9):1381-1389. doi: 10.1001/jamaoncol.2020.2922.
JAMA Oncol. 2020.
PMID: 32729887
Free PMC article.
Item in Clipboard
Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk.
Geuzinge HA, Heijnsdijk EAM, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MMA; FaMRIsc study group.
Geuzinge HA, et al.
Breast. 2021 Apr;56:1-6. doi: 10.1016/j.breast.2021.01.002. Epub 2021 Jan 18.
Breast. 2021.
PMID: 33515770
Free PMC article.
Item in Clipboard
Cite
Cite